MBX Biosciences, Inc.
MBX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001776111
In the last 90 days, MBX Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 172 institutions reported holding it in 13F filings for Q2 2026, worth $3.06B in total; no superinvestor holds it.
Superinvestors holding MBX, Q2 2026
No superinvestor reported holding MBX in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of MBX each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q4 2024
0 superinvestors holding at quarter end
- Sold out
- Soros Fund Management
Q3 2024
1 superinvestor holding at quarter end